78 related articles for article (PubMed ID: 16525591)
1. Thrombolysis in fulminant purpura: observations on changes in microcirculatory perfusion during successful treatment.
Spronk PE; Rommes JH; Schaar C; Ince C
Thromb Haemost; 2006 Mar; 95(3):576-8. PubMed ID: 16525591
[No Abstract] [Full Text] [Related]
2. Recombinant tissue plasminogen activator treatment in two infants with fulminant meningococcemia.
Zenz W; Muntean W; Gallistl S; Zobel G; Grubbauer HM
Pediatrics; 1995 Jul; 96(1 Pt 1):144-8. PubMed ID: 7596694
[No Abstract] [Full Text] [Related]
3. Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans.
Horne MD
Crit Care Med; 1997 Jun; 25(6):909. PubMed ID: 9201041
[No Abstract] [Full Text] [Related]
4. Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans.
Zenz W; Bodó Z; Zobel G; Fanconi S; Rettenbacher A
Crit Care Med; 1998 May; 26(5):969-71; author reply 972-3. PubMed ID: 9590330
[No Abstract] [Full Text] [Related]
5. Purpura fulminans in paroxysmal nocturnal haemoglobinuria.
Watt SG; Winhoven S; Hay CR; Lucas GS
Br J Haematol; 2007 May; 137(4):271. PubMed ID: 17456051
[No Abstract] [Full Text] [Related]
6. Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans.
Nadel S; De Munter C; Britto J; Habibi P; Levin M
Crit Care Med; 1998 May; 26(5):971-2; author reply 972-3. PubMed ID: 9590331
[No Abstract] [Full Text] [Related]
7. Thrombolytic therapy in the acute management of frostbite injuries.
Wagner C; Pannucci CJ
Air Med J; 2011; 30(1):39-44. PubMed ID: 21211711
[TBL] [Abstract][Full Text] [Related]
8. Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans.
Aiuto LT; Barone SR; Cohen PS; Boxer RA
Crit Care Med; 1997 Jun; 25(6):1079-82. PubMed ID: 9201064
[TBL] [Abstract][Full Text] [Related]
9. [Replacement therapy with protein C for meningococcal sepsis and fulminant purpura in pediatric patients].
Llinares Tello F; Hernández Prats C; Burgos San José A; Bosacoma Ros N; Alcalá Minagorre P; López Rodríguez F; Reig Sáenz R; Marco Vera P; Ordovás Baines JP
Farm Hosp; 2004; 28(2):130-6. PubMed ID: 15101805
[TBL] [Abstract][Full Text] [Related]
10. Massive subperiosteal hemorrhage and femoral shaft osteonecrosis: a complication of tissue plasminogen activator therapy for purpura fulminans.
Rodgers WB; Kennedy JG; Hergreuter CA; Kasser JR
Am J Orthop (Belle Mead NJ); 2000 Apr; 29(4):315-9. PubMed ID: 10784021
[TBL] [Abstract][Full Text] [Related]
11. Thrombolysis in acute cerebrovascular disease: indications and limitations.
Hacke W; Ringleb P; Stingele R
Thromb Haemost; 1999 Aug; 82(2):983-6. PubMed ID: 10605813
[No Abstract] [Full Text] [Related]
12. Thrombolysis of prosthetic tricuspid valve thrombosis with human recombinant tissue plasminogen activator in an adolescent.
Bolz D; Kühne T; Jivraj R; Hammer J
Pediatr Cardiol; 2000; 21(4):397-400. PubMed ID: 10865025
[TBL] [Abstract][Full Text] [Related]
13. Intravenous tissue plasminogen activator in central retinal artery occlusion.
Falavarjani KG; Modarres M
Am J Ophthalmol; 2009 Jun; 147(6):1105; author reply 1105-6. PubMed ID: 19463547
[No Abstract] [Full Text] [Related]
14. Topical nitroglycerin and pain in purpura fulminans.
Meyer MT; Irazuzta JE; Tozibikian H
J Pediatr; 1999 May; 134(5):639-41. PubMed ID: 10228302
[TBL] [Abstract][Full Text] [Related]
15. Concomitant nitroglycerin and rTPA.
Massel D
Am Heart J; 1997 Jun; 133(6):713-4. PubMed ID: 9200401
[No Abstract] [Full Text] [Related]
16. Purpura fulminans during meningococcal sepsis treated with Drotrecogin alpha. A clinical case.
Belloni G; Ramello P; Salcuni MR; Scavone L; Girotto M; Di Bassiano F
Minerva Anestesiol; 2006 Apr; 72(4):249-54. PubMed ID: 16570037
[TBL] [Abstract][Full Text] [Related]
17. Tissue plasminogen activator after retinal artery occlusion.
Marmor MF
Ophthalmology; 1999 Dec; 106(12):2231-2. PubMed ID: 10599645
[No Abstract] [Full Text] [Related]
18. The results of arterial thrombolysis.
Kroese AJ; Staxrud LE
Ann Chir Gynaecol; 1995; 84(4):350-3. PubMed ID: 8687078
[No Abstract] [Full Text] [Related]
19. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion.
Hattenbach LO; Kuhli-Hattenbach C; Scharrer I; Baatz H
Am J Ophthalmol; 2008 Nov; 146(5):700-6. PubMed ID: 18718570
[TBL] [Abstract][Full Text] [Related]
20. Intravenous thrombolysis in German stroke units before and after regulatory approval of recombinant tissue plasminogen activator.
Weimar C; Kraywinkel K; Maschke M; Diener HC;
Cerebrovasc Dis; 2006; 22(5-6):429-31. PubMed ID: 16912477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
